Published in Mediators Inflamm on September 23, 2013
Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-control analysis within the Nurses' Health Study II Cohort. Environ Health Perspect (2014) 1.13
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model. Mol Autism (2015) 0.87
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes. Clin Med Insights Pediatr (2016) 0.82
Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol (2014) 0.79
Anti-Lipid IgG Antibodies Are Produced via Germinal Centers in a Murine Model Resembling Human Lupus. Front Immunol (2016) 0.75
Preeclampsia, placental insufficiency, autism, and antiphospholipid antibodies-reply. JAMA Pediatr (2015) 0.75
Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol (2017) 0.75
Serologic Markers of Autism Spectrum Disorder. J Mol Neurosci (2017) 0.75
Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ (2012) 11.55
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord (1997) 3.45
Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J Child Psychol Psychiatry (2002) 2.80
The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun (2011) 2.24
Autoimmunity in autism. Curr Opin Investig Drugs (2009) 1.49
Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clin Neurol Neurosurg (2005) 1.42
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol (1997) 1.40
Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) (2003) 1.38
Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun (2008) 1.34
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun (1993) 1.28
Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum (2007) 1.27
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus (1999) 1.21
Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci (2007) 1.11
Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1988) 1.10
Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun (2010) 1.07
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol (2008) 1.04
Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service. J Child Psychol Psychiatry (1992) 1.03
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost (1991) 1.00
Antiphospholipid syndrome infectious origin. J Clin Immunol (2004) 1.00
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest (1997) 0.98
Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus (2003) 0.97
Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol Autism (2011) 0.94
Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci U S A (1985) 0.94
Infection in the first 2 years of life and autism spectrum disorders. Pediatrics (2007) 0.92
Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol (2002) 0.89
Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav Immun (2011) 0.88
Are there enhanced MBP autoantibodies in autism? J Autism Dev Disord (2007) 0.86
How relevant are GFAP autoantibodies in autism and Tourette Syndrome? J Autism Dev Disord (2007) 0.83
Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis (1992) 0.83
Pediatric antiphospholipid syndrome. Isr Med Assoc J (2008) 0.81
Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis. J Neuroimmunol (2007) 0.80
Detection of antinuclear and antilaminin antibodies in autistic children who received thimerosal-containing vaccines. J Biomed Sci (2004) 0.79
Using maternally reported data to investigate the association between early childhood infection and autism spectrum disorder: the importance of data source. Paediatr Perinat Epidemiol (2012) 0.79
Hyperactivity induced by antiphospholipid syndrome serum. Ann N Y Acad Sci (2009) 0.78
Beyond the "syndrome": antiphospholipid antibodies as risk factors. Arthritis Rheum (2012) 0.77
Lessons from experimental APS models. Lupus (1998) 0.77
Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology (2010) 0.77
A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1991) 0.77
Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology (2011) 3.15
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Concern The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol (2005) 2.41
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun (2011) 2.24
Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics (2012) 2.18
Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr (2012) 2.14
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
The human placenta methylome. Proc Natl Acad Sci U S A (2013) 1.86
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res (2008) 1.72
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci (2007) 1.55
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ Health Perspect (2014) 1.54
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51
Autoimmunity in autism. Curr Opin Investig Drugs (2009) 1.49
Ultra Low Density and Highly Crosslinked Biocompatible Shape Memory Polyurethane Foams. J Polym Sci B Polym Phys (2012) 1.48
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol (2010) 1.46
Research priorities for developmental-behavioral pediatrics: a DBPNet consensus study. J Dev Behav Pediatr (2012) 1.43
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics (2006) 1.39
Is autism an autoimmune disease? Autoimmun Rev (2004) 1.37
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res (2008) 1.37
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun (2008) 1.34
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31
Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord (2014) 1.26
Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord (2013) 1.25
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol (2003) 1.21
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Genetic and immunologic considerations in autism. Neurobiol Dis (2002) 1.19
Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun (2013) 1.17
A review of autism and the immune response. Clin Dev Immunol (2004) 1.15
Doula care, early breastfeeding outcomes, and breastfeeding status at 6 weeks postpartum among low-income primiparae. J Obstet Gynecol Neonatal Nurs (2009) 1.14
Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci (2007) 1.11
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol (2009) 1.11
Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord (2012) 1.11
Maternal autoantibodies in autism. Arch Neurol (2012) 1.08
Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics (2012) 1.08
Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun (2010) 1.07
A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord (2011) 1.06
In search of cellular immunophenotypes in the blood of children with autism. PLoS One (2011) 1.04
Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A (2012) 1.04
Exposure to air pollution in critical prenatal time windows and IgE levels in newborns. Pediatr Allergy Immunol (2011) 1.04
Air pollution exposure during critical time periods in gestation and alterations in cord blood lymphocyte distribution: a cohort of livebirths. Environ Health (2010) 1.03
Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev (2004) 1.00
Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol (2003) 0.99
Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model. J Neuroimmunol (2012) 0.98
Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am J Gastroenterol (2004) 0.98
Polyurethane shape-memory polymers demonstrate functional biocompatibility in vitro. Macromol Biosci (2007) 0.98
Air pollution and lymphocyte phenotype proportions in cord blood. Environ Health Perspect (2005) 0.97
The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract (2011) 0.96
Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev (2002) 0.96
Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun (2013) 0.95
Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res (2008) 0.93
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype? J Autism Dev Disord (2007) 0.93
Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet (2010) 0.92
Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord (2014) 0.91
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics (2010) 0.90
MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res (2011) 0.89
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med (2013) 0.89
Inflammatory macrophage phenotype in BTBR T+tf/J mice. Front Neurosci (2013) 0.88
Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav Immun (2011) 0.88
The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology (2002) 0.88